Search - tctmd.com

Displaying 21 - 40 of 254

Sort: Relevancy | Date

News Conference News AHA 2024

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

Caitlin E. Cox

November 17, 2024

News Conference News AHA 2024

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

Michael O'Riordan

November 17, 2024

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Conference News AHA 2024

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

Yael L. Maxwell

November 16, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

Michael O'Riordan

November 13, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Daily News

Coronary CTA Reimbursement for US Hospitals to Double in 2025

Yael L. Maxwell

November 08, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2024

Shelley Wood

November 01, 2024

News Conference News TCT 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Caitlin E. Cox

October 30, 2024

Presentation TCT 2024

Keynote Lecture II: Master Clinician Perspectives: How Will the Recent Evidence Impact Guidelines and Clinical Practice?

Presenter: Patrick O'Gara

October 30, 2024

News Conference News TCT 2024

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

Yael L. Maxwell

October 29, 2024

News Conference News TCT 2024

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

Todd Neale

October 29, 2024

Presentation TCT 2024

When to Treat: Natural History, Progression, and Treatment Guidelines in Primary MR

Presenter: Martin Swaans

October 29, 2024

News Conference News TCT 2024

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

Todd Neale

October 28, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

Advertisement

Email Nudges Spur Patients With a History of Acute MI to Get Flu Shots

GLORIOUS: Neither Exenatide Nor Restrictive Oxygenation Boost CV Surgery Outcomes

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Coronary CTA Reimbursement for US Hospitals to Double in 2025

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

TCTMD’s Top 10 Most Popular Stories for October 2024

QFR No Match for FFR in Guiding Revascularizations: FAVOR III Europe

Keynote Lecture II: Master Clinician Perspectives: How Will the Recent Evidence Impact Guidelines and Clinical Practice?

ALIGN-AR at 2 Years Shows Promise for TAVI With Trilogy in Aortic Regurgitation

DRAMI: No Clear Winner for Distal vs Traditional Radial Access in STEMI

When to Treat: Natural History, Progression, and Treatment Guidelines in Primary MR

TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content